Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. 2008

Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan. yukio@med.nagoya-u.ac.jp

Recently, endothelial dysfunction induced by an uncoupling of vascular endothelial growth factor (VEGF) and nitric oxide has been implicated in the pathogenesis of diabetic nephropathy (DN). Investigating the pathogenesis of DN has been limited, however, because of the lack of animal models that mimic the human disease. In this report, pancreatic beta cell-specific calmodulin-overexpressing transgenic (CaMTg) mice, a potential new model of DN, are characterized with particular emphasis on VEGF and related molecules. CaMTg mice developed hyperglycemia at 3 wk and persistent proteinuria by 3 mo. Morphometric analysis showed considerable increases in the glomerular and mesangial areas with deposition of type IV collagen. Moreover, the pathologic hallmarks of human DN (mesangiolysis, Kimmelstiel-Wilson-like nodular lesions, exudative lesions, and hyalinosis of afferent and efferent arteries with neovascularization) were observed. In addition, increased VEGF expression was associated with an increased number of peritubular capillaries. Expression of endothelial nitric oxidase synthase was reduced and that of VEGF was markedly elevated in CaMTg mice kidney compared with nontransgenic mice. No differences in VEGF receptor-1 or VEGF receptor-2 expression were observed between CaMTg mice and nontransgenic kidneys. In summary, CaMTg mice develop most of the distinguishing lesions of human DN, and the elevated VEGF expression in the setting of diminished endothelial nitric oxide synthase expression may lead to endothelial proliferation and dysfunction. This model may prove useful in the study of the pathogenesis and treatment of DN.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D002147 Calmodulin A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium-Dependent Activator Protein,Calcium-Dependent Regulator,Bovine Activator Protein,Cyclic AMP-Phosphodiesterase Activator,Phosphodiesterase Activating Factor,Phosphodiesterase Activator Protein,Phosphodiesterase Protein Activator,Regulator, Calcium-Dependent,AMP-Phosphodiesterase Activator, Cyclic,Activating Factor, Phosphodiesterase,Activator Protein, Bovine,Activator Protein, Calcium-Dependent,Activator Protein, Phosphodiesterase,Activator, Cyclic AMP-Phosphodiesterase,Activator, Phosphodiesterase Protein,Calcium Dependent Activator Protein,Calcium Dependent Regulator,Cyclic AMP Phosphodiesterase Activator,Factor, Phosphodiesterase Activating,Protein Activator, Phosphodiesterase,Protein, Bovine Activator,Protein, Calcium-Dependent Activator,Protein, Phosphodiesterase Activator,Regulator, Calcium Dependent
D002196 Capillaries The minute vessels that connect arterioles and venules. Capillary Beds,Sinusoidal Beds,Sinusoids,Bed, Sinusoidal,Beds, Sinusoidal,Capillary,Capillary Bed,Sinusoid,Sinusoidal Bed
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001160 Arterioles The smallest divisions of the arteries located between the muscular arteries and the capillaries. Arteriole

Related Publications

Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
December 2010, Journal of the neurological sciences,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
July 1999, Journal of biochemistry,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
October 2013, The Journal of surgical research,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
November 1995, The Journal of the Association of Physicians of India,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
December 1998, The Journal of membrane biology,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
September 1996, Biochemical and biophysical research communications,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
September 2002, Laboratory investigation; a journal of technical methods and pathology,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
November 2014, Journal of the American Society of Nephrology : JASN,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
January 1998, Nihon rinsho. Japanese journal of clinical medicine,
Yukio Yuzawa, and Ichiro Niki, and Tomoki Kosugi, and Shoichi Maruyama, and Futoshi Yoshida, and Motohiro Takeda, and Yoshiaki Tagawa, and Yukiko Kaneko, and Toshihide Kimura, and Noritoshi Kato, and Jyunichiro Yamamoto, and Waichi Sato, and Takahiko Nakagawa, and Seiichi Matsuo
April 1958, Lancet (London, England),
Copied contents to your clipboard!